CRISPR: Move Beyond Differencesby Charis Thompson, NatureJune 24th, 2015Researchers and ethicists need to see past what can seem to be gendered debates when it comes to the governance of biotechnology.
The Lessons of Asilomar for Today’s Scienceby Alexander Capron, The New York TimesMay 28th, 2015Attempts to use new gene editing techniques to "improve" our descendants raises profound ethical and social issues, and a group dominated by scientists is too self-interested and unrepresentative to take them on.
Innovation and Equity in an Age of Gene Editingby Charis Thompson, Ruha Benjamin, Jessica Cussins and Marcy Darnovsky, The GuardianMay 19th, 2015As experts gather in Atlanta to discuss the rights and wrongs of editing human genomes, four of the attendees explain why it is vital to put social justice at the heart of the debate.
Science is Often Flawed. It's Time we Embraced That.by Julia Belluz and Steven Hoffman, VoxMay 13th, 2015That science can fail shouldn't come as a surprise to anyone. It's a human construct, after all. And if we simply accepted that science often works imperfectly, we'd be better off.
Stopping or Selling Human Germline Modification?by Pete Shanks, Biopolitical TimesMay 7th, 2015Debate about human germline engineering has taken off since publication of a paper describing failed attempts to genetically modify a human embryo.